Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma

Name: Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma
License: Public Domain

The Netherlands Cancer Institute

ClinicalTrials.gov · Datasets · License: Public Domain

malignant melanoma stage iii

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 181757
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.